Healthcare · Biotechnology · NASDAQ
| Market cap | $80.75B |
|---|---|
| Trailing P/E | 16.7 |
| FCF yield | 4.4% |
| Revenue growth (YoY) | +1.0% |
| EPS growth (YoY) | -2.8% |
| FCF/share growth (YoY) | +12.8% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
Regeneron Pharmaceuticals, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Jun 5, 2026 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Dec 12, 2025 |
| Byron Donalds | House | Sell | $1,001 - $15,000 | May 5, 2025 |
| Jefferson Shreve | House | Sell | $15,001 - $50,000 | Apr 25, 2025 |
| Rob Bresnahan | House | Sell | $1,001 - $15,000 | Apr 8, 2025 |
| Julie Johnson | House | Buy | $1,001 - $15,000 | Feb 7, 2025 |
| Josh Gottheimer | House | Sell | $1,001 - $15,000 | Feb 6, 2025 |
| Jonathan Jackson | House | Sell | $15,001 - $50,000 | Dec 3, 2024 |
| Greg Landsman | House | Sell | $1,001 - $15,000 | Oct 29, 2024 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Sep 7, 2023 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Aug 8, 2023 |
| Donald Sternoff Honorable Beyer | House | Buy | $1,001 - $15,000 | Jul 25, 2021 |